Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

EORTC trial non-Hodgkin lymphomas.

R Somers, J M Burgers, M Qasim

    European Journal of Cancer & Clinical Oncology
    |March 1, 1987
    PubMed
    Summary

    This EORTC trial on non-Hodgkin lymphomas found that follicular lymphomas have a better prognosis than diffuse lymphomas. Stage IV disease with bone marrow involvement had a better outlook than other stage IV cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Relationships between paddock-level pasture mass and cow data derived from GPS and behavior-monitoring on-animal sensors in rotationally grazed dairy systems.

    Journal of dairy science·2024
    Same author

    Prevalence of Gram positive bacteria in the affected individuals of Otitis media with effusion from the indigenous population of Southern Punjab, Pakistan: first report.

    Brazilian journal of biology = Revista brasleira de biologia·2023
    Same author

    Spectroscopic and crystallographic analysis of nephrite jade gemstone using laser induced breakdown spectroscopy, Raman spectroscopy, and X-ray diffraction.

    Heliyon·2022
    Same author

    Novel NARC-G1 garlic: comparative allicin quantification with morpho-biochemical & genetic profiling.

    Brazilian journal of biology = Revista brasleira de biologia·2022
    Same author

    Infant botulism: Report of a misleading case and important key messages.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2022
    Same author

    Acaricide resistance in Boophilus microplus ticks collected from two ecological Zones of Khyber Pakhtunkhwa, Pakistan.

    Brazilian journal of biology = Revista brasleira de biologia·2022

    Area of Science:

    • Hematology
    • Oncology
    • Clinical Trials

    Background:

    • Non-Hodgkin lymphomas (NHL) encompass a heterogeneous group of lymphoid malignancies.
    • Accurate staging and histological classification are crucial for predicting prognosis and guiding treatment in NHL.

    Purpose of the Study:

    • To present results from the European Organisation for Research and Treatment of Cancer (EORTC) trial 20751 evaluating treatment strategies for non-Hodgkin lymphomas.
    • To analyze the impact of histological subtype and disease stage on patient outcomes.

    Main Methods:

    • A total of 468 patients with non-Hodgkin lymphomas were treated, with treatment stratified by stage.
    • Histological subtypes were classified using the Kiel classification, distinguishing between low-grade follicular and diffuse patterns, and high-grade lymphomas.
    • Treatment modalities included radiotherapy and various chemotherapy regimens (Vincristine, Cyclophosphamide, Prednisone, Adriamycin, VM26).

    Main Results:

    • Five-year survival rates varied by stage: Stage I (85%), Stage II (55%), Stage III (55%), and Stage IV (45%).
    • Low-grade lymphomas with a follicular pattern showed better survival (80%) compared to diffuse patterns (50%), and both were better than high-grade lymphomas (35%).
    • In advanced stages (III and IV), follicular lymphomas had longer relapse-free and overall survival compared to diffuse histology lymphomas.

    Conclusions:

    • Histological subtype significantly impacts prognosis in non-Hodgkin lymphomas, with follicular patterns generally faring better than diffuse ones.
    • Stage IV disease limited to bone marrow involvement demonstrated a more favorable prognosis compared to other stage IV presentations.
    • While treatment was stratified by stage, specific chemotherapy schedules for advanced disease did not show significant differences in remission or survival rates.

    Related Experiment Videos